Heinz J. Klumpen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Bone Mineral Density Does Not Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial.
Journal: Digestive diseases (Basel, Switzerland)
Published: April 18, 2025
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial.
Journal: United European gastroenterology journal
Published: April 16, 2024
Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma.
Journal: European journal of radiology
Published: July 17, 2023
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients.
Journal: Journal of cachexia, sarcopenia and muscle
Published: October 21, 2022
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial.
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial.
Journal: Hepatology communications
Published: October 01, 2022
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
Journal: JHEP reports : innovation in hepatology
Published: July 22, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 23, 2022
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.
Journal: Journal of cancer research and clinical oncology
Published: March 20, 2021
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization.
Journal: EJNMMI research
Published: March 03, 2021
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?
Journal: Neuroendocrinology
Published: November 12, 2019
Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience.
Journal: ISRN hepatology
Published: January 01, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026